Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437888 · ClinicalTrials.gov registry record · Early Phase 1
Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty
A Early Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 200
- Enrollment target
NCT04437888 is a Early Phase 1 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT04437888, a Early Phase 1 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 200 participants
- Enrollment target
Study Summary
Prospective randomized double blinded, placebo controlled study that will evaluate the effect of intra-operative ketamine administration on post-operative analgesic requirements and self-reported pain in patients undergoing total hip and total knee arthroplasty who demonstrate high levels of pain catastrophizing.
Interventions
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2024-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04437888
The ClinicalTrials.gov registry entry for NCT04437888 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine is the first listed.
NCT04437888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04437888 about?
NCT04437888 is a clinical study titled "Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty". Prospective randomized double blinded, placebo controlled study that will evaluate the effect of intra-operative ketamine administration on post-operative analgesic requirements and self-reported pain in patients undergoing total hip and total knee arthroplasty who demonstrate high levels of pain ca...
What is the current status of trial NCT04437888?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 200 participants. The study started on 2020-09-14. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT04437888?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT04437888?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.